CD44, a transmembrane glycoprotein and receptor to hyaluronic acid, regulates epithelial-mesenchymal transition (EMT) and cell invasion, but its precise role in GBM is not fully understood [19]. The gene discussed is CD44; the disease is glioblastoma.